ATRA
Price
$6.57
Change
-$1.26 (-16.09%)
Updated
Jan 17 closing price
Capitalization
37.84M
PHAT
Price
$6.96
Change
-$0.00 (-0.00%)
Updated
Jan 17 closing price
Capitalization
475.91M
45 days until earnings call
Ad is loading...

ATRA vs PHAT

Header iconATRA vs PHAT Comparison
Open Charts ATRA vs PHATBanner chart's image
Atara Biotherapeutics
Price$6.57
Change-$1.26 (-16.09%)
Volume$934.13K
Capitalization37.84M
Phathom Pharmaceuticals
Price$6.96
Change-$0.00 (-0.00%)
Volume$754.61K
Capitalization475.91M
ATRA vs PHAT Comparison Chart
Loading...
ATRA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PHAT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ATRA vs. PHAT commentary
Jan 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ATRA is a Hold and PHAT is a Hold.

Ad is loading...
COMPARISON
Comparison
Jan 19, 2025
Stock price -- (ATRA: $6.57 vs. PHAT: $6.96)
Brand notoriety: ATRA and PHAT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ATRA: 489% vs. PHAT: 69%
Market capitalization -- ATRA: $37.84M vs. PHAT: $475.91M
ATRA [@Biotechnology] is valued at $37.84M. PHAT’s [@Biotechnology] market capitalization is $475.91M. The market cap for tickers in the [@Biotechnology] industry ranges from $368.92B to $0. The average market capitalization across the [@Biotechnology] industry is $2.37B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ATRA’s FA Score shows that 0 FA rating(s) are green whilePHAT’s FA Score has 0 green FA rating(s).

  • ATRA’s FA Score: 0 green, 5 red.
  • PHAT’s FA Score: 0 green, 5 red.
According to our system of comparison, both ATRA and PHAT are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ATRA’s TA Score shows that 5 TA indicator(s) are bullish while PHAT’s TA Score has 4 bullish TA indicator(s).

  • ATRA’s TA Score: 5 bullish, 5 bearish.
  • PHAT’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, both ATRA and PHAT are a good buy in the short-term.

Price Growth

ATRA (@Biotechnology) experienced а -57.75% price change this week, while PHAT (@Biotechnology) price change was +0.29% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.44%. For the same industry, the average monthly price growth was +2.66%, and the average quarterly price growth was -1.92%.

Reported Earning Dates

ATRA is expected to report earnings on Aug 12, 2024.

PHAT is expected to report earnings on May 13, 2025.

Industries' Descriptions

@Biotechnology (-1.44% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PHAT($476M) has a higher market cap than ATRA($37.8M). PHAT YTD gains are higher at: -14.286 vs. ATRA (-50.639). ATRA has higher annual earnings (EBITDA): -123.21M vs. PHAT (-272.21M). PHAT has more cash in the bank: 335M vs. ATRA (67.2M). ATRA has less debt than PHAT: ATRA (49.9M) vs PHAT (176M). ATRA has higher revenues than PHAT: ATRA (100M) vs PHAT (26.3M).
ATRAPHATATRA / PHAT
Capitalization37.8M476M8%
EBITDA-123.21M-272.21M45%
Gain YTD-50.639-14.286354%
P/E RatioN/AN/A-
Revenue100M26.3M380%
Total Cash67.2M335M20%
Total Debt49.9M176M28%
FUNDAMENTALS RATINGS
ATRA: Fundamental Ratings
ATRA
OUTLOOK RATING
1..100
11
VALUATION
overvalued / fair valued / undervalued
1..100
77
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
94
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
75

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ATRAPHAT
RSI
ODDS (%)
Bearish Trend 11 days ago
90%
Bullish Trend 11 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 11 days ago
85%
Bullish Trend 11 days ago
88%
Momentum
ODDS (%)
Bullish Trend 11 days ago
83%
Bearish Trend 11 days ago
83%
MACD
ODDS (%)
Bullish Trend 11 days ago
80%
N/A
TrendWeek
ODDS (%)
Bullish Trend 11 days ago
81%
Bearish Trend 11 days ago
84%
TrendMonth
ODDS (%)
Bullish Trend 11 days ago
80%
Bearish Trend 11 days ago
84%
Advances
ODDS (%)
Bullish Trend 13 days ago
82%
Bullish Trend 23 days ago
85%
Declines
ODDS (%)
Bearish Trend 11 days ago
87%
Bearish Trend 11 days ago
84%
BollingerBands
ODDS (%)
Bearish Trend 11 days ago
85%
Bullish Trend 11 days ago
76%
Aroon
ODDS (%)
Bearish Trend 11 days ago
89%
Bearish Trend 11 days ago
82%
View a ticker or compare two or three
Ad is loading...
ATRA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PHAT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CBNK29.070.64
+2.25%
Capital Bancorp
LHX218.16-0.32
-0.15%
L3Harris Technologies
SLM27.98-0.15
-0.53%
SLM Corp
TTGT17.39-0.50
-2.79%
TechTarget
USAU6.72-0.55
-7.57%
US Gold Corp

ATRA and

Correlation & Price change

A.I.dvisor indicates that over the last year, ATRA has been closely correlated with IKNA. These tickers have moved in lockstep 72% of the time. This A.I.-generated data suggests there is a high statistical probability that if ATRA jumps, then IKNA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ATRA
1D Price
Change %
ATRA100%
-16.09%
IKNA - ATRA
72%
Closely correlated
-0.66%
AMLX - ATRA
55%
Loosely correlated
+2.86%
ABCZF - ATRA
53%
Loosely correlated
N/A
RAPT - ATRA
37%
Loosely correlated
+0.84%
PHAT - ATRA
36%
Loosely correlated
N/A
More